BLOOMINGTON, Ind., Jan. 19, 2017 -- Megaputer Intelligence announced today that it will host a live webinar series titled “Text Analytics for Pharma” beginning on January 31, 2017. A set of nine free webinars comprising this series will highlight how advanced text analytics helps address typical challenges encountered in the pharmaceutical and life sciences domains:
- Detection of potential adverse events
- Extraction of facts from academic publications
- Analysis of call center transcripts
- Survey data analysis
- Medical device repair notes analysis
- Competitive intelligence
- Social media analysis
Presenters will discuss the underworkings and practical implementations of advanced computational linguistics techniques, as well as the foundations of systems for the analysis of BIG DATA. Topics will be presented by data and text analysis specialists with relevant domain expertise. The webinar series is scheduled to run from January to April 2017.
The webinars will provide business practitioners with a clear understanding of frequently encountered individual tasks and outline the technology, implementation path, results, and benefits of the analytical solutions developed at industry-leading companies for addressing these tasks.
For more information and to register for the webinars, visit www.polyanalyst.com/webinars. Advance registration is encouraged, as availability is limited for each webinar.
About Megaputer Intelligence
Megaputer Intelligence (www.megaputer.com) is a leading developer of data and text mining software and custom analytical solutions for various application domains. Megaputer analytical tools enable over 500 customers worldwide to make informed data-driven decisions.
Megaputer is a registered trademark of Megaputer Intelligence Inc. in the United States and/or other countries. The names of other companies and products mentioned herein may be the trademarks of their respective owners.
For more information: Brian Howard Megaputer Intelligence, Inc. (812) 330-0110 ext. 215 [email protected]


7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing 



